Article
The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
Atherosclerosis - 26 Jan 1996
Hoffer M J, Bredie S J, Boomsma D I, Reymer P W, Kastelein J J, de Knijff P, Demacker P N, Stalenhoef A F, Havekes L M, Frants R R
Abstract excerpt
Familial combined hyperlipidaemia (FCHL) is one of the major genetic causes of coronary heart disease (CHD) and is characterised by elevated levels of plasma cholesterol and/or triglycerides in individuals within a single family. Decreased lipoprotein lipase (LPL) activity has been found in some cases of FCHL. A recent study revealed a common mutation in the LPL gene, LPL(Asn291-->Ser), with a frequency of 9.3%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
